INTRODUCTION
The non-covalent heterodimeric complex formed by platelet glycoproteins IIb and Illa (GPIIb and GPIIIa) is the prototypical member of the integrin family of cell-adhesion receptors, which are characterized by considerable sequence similarity of their respective ac-and fl-subunits (recently reviewed by Phillips et al. [1] ). GPIIIa, which has been identified as the fl-subunit of the integrin subclass termed 'cytoadhesins' [2] , is a single polypeptide chain of 762 residues. Important features of the GPIIIa primary structure [3, 4] include an N-terminal segment of approx. 200 residues, which contains a putative Arg-Gly-Asp recognition site [5] [6] [7] , followed by a proteinase-susceptible region [8] , and a large extracellular domain containing 45 cysteine residues, 31 of which are arranged in a set of four tandem repeats [1, 3, 4 ]. This domain is followed by a short stretch of hydrophobic residues tentatively identified as a membrane-spanning region and a short intracellular sequence extending to the C-terminus [1, 3, 4] .
Although biochemical [5] [6] [7] and immunological [9] data have clearly demonstrated an important role for the N-terminal region of platelet GPIIIa in ligand binding and platelet aggregation, the presence of disulphide bond(s) between the N-terminal and cysteine-rich domains ofthe molecule [8] [9] [10] indicates that regi9ns of GPIIIa distant in linear sequence are in close proximity in the folded structure and could contribute to receptor function. Here we show that our anti-GPIIIa monoclonal antibody, CS-1, which inhibits platelet-fibrin(ogen) interactions [11] , recognizes an epitope contained within residues 349-422 of GPIIIa. As this sequence is present on a central section of GPIIIa distinct from the Arg-Gly-Asp-recognition site on the N-terminus, we propose that the central region of GPIIIa also participates in integrinreceptor function.
MATERIALS AND METHODS

Purification of GPIIb-Ia and development of monoclonal antibody CS-1
The GPIIb-IIIa complex was purified by a combination of lentil-lectin affinity chromatography [12] and Sepharose-4B gelfiltration chromatography of solubilized platelet membrane proteins [13] as previously described [11] .
Also previously described was the development of CS-1 by standard hybridoma technology [14] with purified GPIIb-IIIa as the antigen; immunoblotting demonstrated that CS-I is specific for non-reduced GPIIIa, but does not recognize the completely reduced polypeptide. Radiolabelled-ligand binding studies showed that CS-1 recognizes approx. 55000 sites/platelet and binds with a dissociation constant in the nanomolar range, independent of the state of platelet activation. We have also shown that CS-1 causes a 2.5-3-fold reduction in binding of fibrinogen and soluble fibrin polymers to ADP-and thrombin-GPIIb-IIIa (250 ,ug) was applied to an h.p.s.e.c. system purified by electroelution using a CBS Scientific electroelution apparatus as described by Hunkapillar et al. [19] . The samples were collected, and approx. 5 % of the total sample was analysed by SDS/PAGE to ensure that the correct polypeptide was electroeluted and to obtain an estimate of its purity. Electrophoretic transfer to poly(vinylidene difluoride) (PVDF)
As an alternative to electroelution, peptides for N-terminal amino acid sequence analysis were transferred from 10 % (w/v) polyacrylamide gels to PVDF (Immobilon-P, Millipore) membranes by a minor modification of the procedure of Matsudaira [20] . The purified, 49 kDa a-chymotryptic fragment (the smallest fragment recognized by CS-1) was subjected to partial reduction with dithiothreitol to separate the constituent polypeptides of the fragment. This was achieved by a modification of the selective reduction technique of Calvete et al. [9] . The concentration of the electroeluted fragment was estimated by microbiuret assay [21] . The fragment was precipitated with ethanol (9 [22] and PEPTIDESTRUCTURE (in particular, the surface probability algorithim of Emini et al. and Janin et al. [23, 24] and the hydrophobicity algorithim of Kyte & Doolittle [25] of the GCG Sequence Analysis Software Package [26] ) were used for analyses of the primary structure of GPIIIa.
RESULTS AND DISCUSSION Limited proteolysis with trypsin, a-chymotrypsin and staphylococcal V8 proteinase Trypsin, a-chymotrypsin and staphylococcal V8 proteinase, alone or in combination, were all found to make limited cleavages in purified GPIIIa, as evidenced by SDS/PAGE (Fig. la ). An identical gel was electrophoretically transferred to nitrocellulose and probed with HRP.CS-1 (Fig. 2b) . The Note the appearance of the 49+ 1 kDa fragment, which represents a trypsin-resistant core. The proteins from an identical gel were transferred to nitrocellulose and developed with HRP.CS-1. The results (b) demonstrate that a 49 kDa fragment is the smallest fragment generated by tryptic cleavage ofGPIIIa which is recognized by CS-I (molecular mass estimated by comparison with prestained molecular-mass standards; lanes S).
Sequence of the tryptic fragments
To localize this 49 kDa fragment within the GPIIIa molecule, we performed N-terminal amino acid sequence analysis of the electroeluted 49 kDa tryptic fragment. The band was found to contain a mixture of amino acid sequences ( Table 1 ) that were consistent with the published amino acid sequence derived from the cDNA clone of GPIIIa [3, 4] . The predominant sequence (calculated initial yield 66 pmol) was the N-terminal sequence of native GPIIIa (Table 1 , column A) and was easily interpreted without the aid of cDNA sequence. The remaining amino acids that were observed in each cycle of Edman degradation were assigned to their respective sequences using the known amino acid sequence as indicated in Table 1 (columns B, C and D) and were completely consistent with known regions of the GPIIIa molecule. These peptides resulted from cleavage after lysine residues 298 and 302 and after an arginine residue at position 352. The calculated initial yields for these secondary sequences were 16, 20 and 15 pmol respectively, the sum of which is roughly equivalent to the yield of the prominent N-terminal sequence.
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Interpretation of trypsin digestion results
Our interpretation of the trypsin digestion results is presented in Scheme 1. Limited proteolysis of GPIIIa by trypsin yields a series of two-chain core fragments comprised of a 19 kDa Nterminal segment connected by disulphide bond(s) to one of four polypeptides, which begin at residues 299, 303, 349 or 423 or GPIIIa and may extend to the C-terminus of intact GPIIIa (based on molecular-mass estimates). The observation that removal of residues 300-422 of GPIIIa coincides with loss of immunoreactivity towards CS-1 strongly suggests that the epitope recognized by our monoclonal antibody is contained 'within this mid-molecule segment, although these data alone do not rule out the possibility that interactions between residues 300-422 and the N-terminus could be involved.
Limited proteolysis with a-chymotrypsin
A series of limited proteolysis and partial disulphide-bond reduction experiments were conducted to determine if the epitope for CS-I is contained solely within the central domain of GPIIIa. To focus on this question, we purified the smallest immunoreactive fragment produced by a-chymotrypsin (approx. 49 kDa) because digestion with this proteinase resulted in the production of the 49 kDa fragment without the larger undigested fragments (Fig. la, lane 4) . N-Terminal sequence analysis of this electroeluted fragment yielded a mixture of two amino acid sequences ( Table 2 ) that could be interpreted with reference to the published amino acid sequence [3, 4] . The predominant sequence (initial yield 52 pmol) corresponded to the N-terminus of GPIIIa (Table  2 , column A). The secondary sequence corresponded to residues 349-366 of intact GPIIIa (Table 2 , column B). Consistent with the cleavage specificity of a-chymotrypsin, this fragment resulted from cleavage of GPIIIa after tyrosine-348. Upon reduction, the light and heavy chains are separated and migrate with molecular masses corresponding to a 19 + 1/20 + I kDa doublet and 5&+ 4 kDa (see the parenthetic note above about increase in molecular mass on reduction), respectively (Fig. 3a, lane 2) Partial reduction of the 49 kDa a-chymotrypsin fragment In order to determine if the N-terminal portion of the 49 kDa fragment of GPIIIa contributes to formation of the epitope recognized by monoclonal antibody CS-1, we employed the technique of Calvete et al. [9] to reduce selectively the disulphide bond(s) between the light and heavy chains with dithiothreitol. Analysis of the gel shows that, upon complete reduction (Fig. 3,  lane 2) , the 58 kDa fragment and the N-terminal segment (19/20 kDa) of the a-chymotryptic fragment were separated.
Densitometric scans revealed the presence of similar quantities of the N-terminal fragment after incubation with dithiothreitol concentrations corresponding to a 1:1, 0.25: 1, 0.5:1, and 2:1 ratio of the half-cystine content of the 49 kDa fragment (Fig. 3,  lanes 4 , 5, 7 and 8 respectively).
In the presence of sub-stoichiometric concentrations of reducing agent, the heavy chain migrated with an apparent molecular mass of 46 + 2 kDa (lanes 5, 7), faster than either the non-reduced (Fig. 3, lane 1) or fully reduced (Fig. 3a, lane 2) 58 kDa fragment. This altered electrophoretic mobility, coupled with the appearance of the N-terminal fragment, indicates that reduction of the disulphide bond(s) joining the two polypeptides which comprise the 49 kDa fragment had been achieved over a limited range of dithiothreitol concentrations.
A gel identical with that in Fig. 3(a) was electrophoretically transferred to nitrocellulose and probed with HRP.CS-1 to determine if the epitope recognized by the monoclonal antibody is contained within the light or heavy chains of the 49 kDa achymotryptic fragment. The lanes corresponding to the intact (Fig. 3b, lane 1) and selectively reduced fragment (Fig. 3b, lanes  5 and 7) were strongly immunoreactive, indicating that CS-1 recognized the larger portion of the fragment, even in the absence of the smaller N-terminal fragment. Moreover, it is noteworthy that immunoreactivity was nearly completely lost after incubation with higher concentrations of reducing agent (Fig. 3b, lanes 2, 4 and 8) . The identity of the weakly immunoreactive bands seen in lanes 2, 4 and 8 is unknown, but they were only observed at high sample loads and were not seen in two other partial-reduction experiments (results not shown).
In order to amplify the small change in electrophoretic mobility which accompanied partial reduction, additional samples of nonreduced, partially reduced, and fully reduced 49 kDac a-chymotryptic fragment were subjected to SDS/PAGE for approximately twice the usual period, until the pre-stained 26.6 kDa molecular-mass marker reached the bottom of a 10 gel. Under these conditions, the mobility of the partially reduced band revealed by Coomassie Blue staining increased by 2.7 % compared with the non-reduced sample; analysis of the corresponding immunoblot revealed a similar 2.6 % increase in mobility of the partially reduced sample. These observations confirm that the main immunoreactive material in lanes 5 and 7 of Fig. 3 corresponds to the partially reduced bands revealed by Coomassie Blue staining in Fig. 3(a) . Since the possibility existed that the species recognized by CSin Fig. 3b (lanes 5 and 7) was the intact 49 kDa fragment which had not yet been reduced by the mild dithiothreitol treatment, the fragment with an apparent molecular mass of 46 kDa was purified by electroelution and subjected to N-terminal amino acid analysis. (19 kDa and 58 kDa respectively), neither of which is immunoreactive (immunoreactivity is denoted by the encircled molecular masses with an asterisk). Under mild dithiothreitol treatment, the N-and C-terminal portions are also separated; however, the disulphide bonds within the C-terminal cysteine-rich core were not fully reduced and this portion migrated with an apparent molecular mass of 46 kDa. In addition, this Cterminal portion maintained immunoreactivity in the absence of the N-terminal component.
of the central region of GPIIIa (GKIRSKVELE; initial yield 27 pmol) and did not contain residues corresponding to the Nterminus of mature GPIIIa. Residues corresponding to the mature N-terminus would have been detected with an initial yield of2 pmol.
Interpretation of the a-chymotrypsin digestion/partial-reduction results Scheme 2 summarizes our results on the localization of the epitope recognized by monoclonal antibody CS-1. a-Chymo-' trypsin cleavage converts intact GPIIIa into a two-chain molecule composed of a 19/20 kDa N-terminal fragment held by disulphide bond(s) to a 58 kDa fragment which begins at residue 349 and may extend to the C-terminus of the intact polypeptide. Limited disulphide-bond reduction releases the N-terminal segment, and the resultant single-chain central fragment retains immunoreactivity toward CS-1. Therefore the a-chymotrypsin data indicate that the epitope recognized by monoclonal antibody CS-1 is contained within residues 349-762. Taken together with the results of trypsin cleavage, which show that removal of residues 300-422 correlates with complete loss -of immunoreactivity (Scheme 1), we conclude that residues 349-422 contain the site on GPIIIa to which monoclonal antibody CS-1 binds. The conformation of this region of GPIIIa is evidently dependent on the presence of intrachain disulphide bonds, as extensive reduction results in loss of immunoreactivity.
We note that Calvete etaL [9] have shown that trypsin digestion of GPIIIa, followed by limited disulphide-bond.reduction, yields a 23 kDa N-terminal fragment containing a single free cysteine residue and a mixture of 80/70 kDa polypeptides containing two Integrin-receptor function of glycoprotein Illa central region cysteine residues. They concluded that a single disulphide bond present within the first 17 kDa of GPIIIa linked the N-terminal region to a 80/70 kDa fragment [9] . Recently, Niewiarowski et al. [10] and Beer [5, 6] have demonstrated that residues 109-171 of GPIIIa contain a site to which synthetic peptides containing the Arg-Gly-Asp sequence, common to all ligands which bind to the platelet GPIIb-IIIa complex, can be chemically cross-linked. Calvete et al. [9] have shown that monoclonal antibody P37 inhibits platelet aggregation and recognizes an N-terminal 17 kDa tryptic fragment of GPIIIa which contains the putative Arg-Gly-Asp recognition site identified by D'Souza et al. [5, 6] .
Whether this is the only region of GPIIIa involved in ligand binding remains open to question. For example, Niewiarowski et al. [10] have reported that a two-chain chymotryptic fragment of GPIIIa lacking residues 130-137 does not bind to immobilized fibrinogen or to immobilized synthetic peptide GRGDSPK; as intact GPIIIa was adsorbed by both these resins, they concluded that their 66 kDa chymotryptic fragment was not involved in fibrinogen binding. Conversely, immunological data suggest a possible role for the 66 kDa fragment in both fibrinogen binding and platelet aggregation [27] [28] [29] .
The observation that the N-terminal segment of GPIIIa is held in close proximity to the central region of GPIIIa and the adjacent cysteine-rich domain by a single disulphide bond [9] suggests that regions of the molecule which are distant in linear sequence can contribute to integrin-receptor function. Our data support this postulate in that monoclonal antibody CS-1 binds to a site contained within residues 349-422 of GPIIIa (the present work) and causes a substantial inhibition of both platelet aggregation and binding fibrin(ogen) to stimulated platelets [11] . We have presented evidence that non-specific steric hindrance cannot explain these effects, since both intact monoclonal antibody and its Fab fragment are equally effective in blocking fibrinogen binding, and quantitatively similar inhibition parameters characterize the ability of CS-1 to block the binding of fibrinogen and fibrin polymers (composed of up to 20 fibrin monomers) to stimulated platelets [11] . Therefore we conclude that the mid-section of GPIIIa either contains a second site for fibrin(ogen) binding or contributes to the formation of a discontinuous ligand recognition region involving both the Nterminal and central regions of the molecule.
Further evidence supporting a role for residues 349-422 in integrin-receptor function comes from the use of predictive algorithims designed to identify sequences likely to be found on the exterior of a folded polypeptide [23] [24] [25] . As illustrated in Fig.   4 , several regions of predicted high surface probability [23, 24] and hydrophilicity [25] were identified between residues 349 and 422. For example, peptide bonds cleaved by chymotrypsin 
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The Figure shows a profile of hydrophilicity [25] (a) and surface probability [23, 24] (b) against residue number calculated with the program PEPTIDESTRUCTURE of the GCG sequence analysis software package [26] .
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